In Focus
Editorials
- Does cigarette smoking do nothing but harm?Shinsuke Fujioka, Ruey-Meei Wu, Yoshio Tsuboi
- Defining response profiles after alemtuzumabRare paradoxical disease exacerbationHeinz Wiendl, Peter A. Calabresi, Sven G. Meuth
Articles
- Outcomes among patients with direct enteral vs nasogastric tube placement after acute strokeRaed A. Joundi, Gustavo Saposnik, Rosemary Martino, Jiming Fang, Joan Porter, Moira K. Kapral
- Long-term cardiovascular prognosis after transient ischemic attackAssociated predictorsAngel Ois, Ana Zabalza, Antia Moreira, Elisa Cuadrado-Godia, Jordi Jimenez-Conde, Eva Giralt-Steinhauer, Ana Rodríguez-Campello, Carolina Soriano-Tarraga, Jaume Roquer
- Onabotulinum toxin-A injections for sleep bruxismA double-blind, placebo-controlled studyWilliam G. Ondo, Jerald H. Simmons, Muhammad H. Shahid, Vera Hashem, Christine Hunter, Joseph Jankovic
- Open AccessRandomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALSMichael Benatar, Joanne Wuu, Peter M. Andersen, Nazem Atassi, William David, Merit Cudkowicz, David Schoenfeld
- Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutationNadine Pelzer, Joost Haan, Anine H. Stam, Lisanne S. Vijfhuizen, Stephany C. Koelewijn, Amber Smagge, Boukje de Vries, Michel D. Ferrari, Arn M.J.M. van den Maagdenberg, Gisela M. Terwindt
- Smoking and Parkinson diseaseEvidence for gene-by-smoking interactionsPei-Chen Lee, Ismaïl Ahmed, Marie-Anne Loriot, Claire Mulot, Kimberly C. Paul, Jeff M. Bronstein, Beate Ritz, Alexis Elbaz
- Smoking affects the interferon beta treatment response in multiple sclerosisEva R. Petersen, Annette B. Oturai, Nils Koch-Henriksen, Melinda Magyari, Per S. Sørensen, Finn Sellebjerg, Helle B. Søndergaard
- Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosisThomas Wehrum, Lena-Alexandra Beume, Oliver Stich, Irina Mader, Mathias Mäurer, Adam Czaplinski, Cornelius Weiller, Sebastian Rauer
- Auditory brainstem function in microcephaly related to Zika virus infectionDimitri Marques Abramov, Tania Saad, Saint-Clair Gomes-Junior, Daniel de Souza e Silva, Izabel Araújo, Maria Elizabeth Lopes Moreira, Vladimir V. Lazarev
- Hearing impairment in patients with myotonic dystrophy type 2Judith van Vliet, Alide A. Tieleman, Baziel G.M. van Engelen, Guillaume Bassez, Laurent Servais, Anthony Béhin, Tanya Stojkovic, Jan Meulstee, Joost A.M. Engel, George Lamas, Bruno Eymard, Wim I.M. Verhagen, Elisabeth Mamelle
What's Happening
Contemporary Issues: Innovations in Education
- Entrustable professional activitiesA useful concept for neurology educationHolli Horak, Robert Englander, Diana Barratt, Jeff Kraakevik, Madhu Soni, Ezgi Tiryaki
Clinical/Scientific Notes
- Infantile-onset hand dystonia with intellectual disabilityClues to ARX mutationsDavid P. Breen, Saadet Mercimek-Andrews, Anthony E. Lang
Reflections: Neurology and the Humanities
NeuroImages
- Hemorrhagic encephalitis associated with H3N2 influenza A viral pneumoniaMahmoud A. AbdelRazek, Michael Leone, Nagagopal Venna
Resident & Fellow Section
- Clinical Reasoning: Siblings with progressive weakness, hypotonia, nystagmus, and hearing lossKallol K. Set, Amanda R.B. Weber, Fatema J. Serajee, Ahm M. Huq
- Education Research: Physician identification and patient satisfaction on an academic neurology inpatient serviceChristopher R. Leon Guerrero, Tracy Anderson, Allyson R. Zazulia
- Journal Club: Relationship between carotid arterial properties and cerebral white matter hyperintensitiesJordan W. Squair, Thalia S. Field, Aaron A. Phillips
- Teaching NeuroImages: Cerebrotendinous xanthomatosisA rare treatable adult-onset lipid storage diseaseMina S. Makary, Yaz Y. Kisanuki, Nessim N. Amin, Hasel W. Slone
Disputes & Debates: Editors' Choice
- Editors' note: Activity limitations and subjective well-being after strokeChafic Karam, Robert C. Griggs
- Author response: Activity limitations and subjective well-being after strokeDarin B. Zahuranec, Lesli E. Skolarus, James F. Burke
- Editors' note: Odor identification as a biomarker of preclinical AD in older adults at riskChafic Karam, Robert C. Griggs
- Reader response: Odor identification as a biomarker of preclinical AD in older adults at riskNicolaas I. Bohnen, Martijn Muller
- Author response: Odor identification as a biomarker of preclinical AD in older adults at riskMarie-Elyse Lafaille-Magnan, John C.S. Breitner